10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 331 filers reported holding 10X GENOMICS INC in Q3 2021. The put-call ratio across all filers is 2.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $545 | -84.7% | 28 | -70.5% | 0.00% | – |
| Q1 2024 | $3,566 | -57.5% | 95 | -36.7% | 0.00% | -100.0% |
| Q4 2023 | $8,394 | +36.6% | 150 | +0.7% | 0.00% | 0.0% |
| Q3 2023 | $6,147 | -26.1% | 149 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8,321 | +0.1% | 149 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $8,313 | -1.2% | 149 | -35.5% | 0.00% | 0.0% |
| Q4 2022 | $8,418 | +180.6% | 231 | +102.6% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 114 | +137.5% | 0.00% | – |
| Q2 2022 | $2,000 | -75.0% | 48 | -51.5% | 0.00% | -100.0% |
| Q1 2022 | $8,000 | -46.7% | 99 | +1.0% | 0.00% | -50.0% |
| Q4 2021 | $15,000 | +66.7% | 98 | +58.1% | 0.00% | +100.0% |
| Q3 2021 | $9,000 | -18.2% | 62 | +6.9% | 0.00% | -50.0% |
| Q2 2021 | $11,000 | -38.9% | 58 | -42.6% | 0.00% | -33.3% |
| Q1 2021 | $18,000 | +157.1% | 101 | +98.0% | 0.00% | +200.0% |
| Q4 2020 | $7,000 | -46.2% | 51 | -66.2% | 0.00% | -66.7% |
| Q2 2020 | $13,000 | – | 151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
| Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
| Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
| Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
| Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
| Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
| RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
| Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
| Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |